SESN2 (Sestrin 2)
<div class="infobox infobox-gene">
| Property | Value | [@budanov2002][@peng2018]
|----------|-------|--
| Gene Symbol | SESN2 |
| Full Name | Sestrin 2 |
| Chromosomal Location | 1p35.3 |
| NCBI Gene ID | 83667 |
| OMIM ID | 607336 |
| Ensembl ID | ENSG00000140299 |
| UniProt ID | Q9Y7X7 |
| Protein Family | Sestrin family (SESN1-3) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Metabolic Syndrome, Cancer, Cardiovascular Disease |
</div>
Overview
SESN2 (Sestrin 2) is a stress-inducible protein that functions as a critical regulator of cellular homeostasis, metabolic adaptation, and stress resistance [1]. It is the most studied member of the sestrin family (SESN1, SESN2, SESN3) and is activated by various stressors including oxidative stress, DNA damage, hypoxia, and mitochondrial dysfunction. SESN2 has emerged as an important protective factor in neurodegenerative diseases through its regulation of [mTOR](/entities/mtor) signaling, AMPK activation, [autophagy](/entities/autophagy) induction, and antioxidant defense [2][3]. This page covers the gene's structure, protein function, molecular pathways, disease associations, and therapeutic implications for neurodegeneration.
Gene and Protein Structure
Genomic Organization
...SESN2 (Sestrin 2)
<div class="infobox infobox-gene">
| Property | Value | [@budanov2002][@peng2018]
|----------|-------|--
| Gene Symbol | SESN2 |
| Full Name | Sestrin 2 |
| Chromosomal Location | 1p35.3 |
| NCBI Gene ID | 83667 |
| OMIM ID | 607336 |
| Ensembl ID | ENSG00000140299 |
| UniProt ID | Q9Y7X7 |
| Protein Family | Sestrin family (SESN1-3) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Metabolic Syndrome, Cancer, Cardiovascular Disease |
</div>
Overview
SESN2 (Sestrin 2) is a stress-inducible protein that functions as a critical regulator of cellular homeostasis, metabolic adaptation, and stress resistance [1]. It is the most studied member of the sestrin family (SESN1, SESN2, SESN3) and is activated by various stressors including oxidative stress, DNA damage, hypoxia, and mitochondrial dysfunction. SESN2 has emerged as an important protective factor in neurodegenerative diseases through its regulation of [mTOR](/entities/mtor) signaling, AMPK activation, [autophagy](/entities/autophagy) induction, and antioxidant defense [2][3]. This page covers the gene's structure, protein function, molecular pathways, disease associations, and therapeutic implications for neurodegeneration.
Gene and Protein Structure
Genomic Organization
The SESN2 gene is located on chromosome 1p35.3 and consists of 11 coding exons spanning approximately 7 kb [1]. The gene is highly conserved across vertebrates, with orthologs identified in mice, zebrafish, and invertebrates. Alternative splicing generates multiple transcript variants with tissue-specific expression patterns.
Protein Architecture
The SESN2 protein (504 amino acids, ~57 kDa) contains several functional domains:
- N-terminal domain (1-170): Leucine-rich repeat (LRR) motif for protein-protein interactions
- Central domain (171-350): Contains the SCF ubiquitin ligase complex interaction region
- C-terminal domain (351-504): Critical for GATOR2 binding and mTORC1 regulation
- Stress-sensing motifs: Multiple phosphorylation sites and redox-sensitive cysteines
The protein adopts a bi-domain structure typical of sestrins, with the LRR domain forming a solenoid that mediates interactions with various signaling proteins [4].
Post-Translational Modifications
SESN2 undergoes complex regulation:
- Phosphorylation: Multiple kinases including AMPK, mTOR, and ERK modify SESN2 activity
- Ubiquitination: SCF^(TRCP) ubiquitin ligase targets SESN2 for degradation
- Oxidation: Redox-sensitive cysteines sense oxidative stress
- Sumoylation: Regulates nuclear localization and stability
Molecular Pathways
mTORC1 Regulation Pathway
SESN2 is a key endogenous inhibitor of mTORC1 signaling:
Mermaid diagram (expand to render)
- GATOR2 binding: SESN2 binds to the GATOR2 complex, blocking mTORC1 activation [4]
- Leucine sensing: SESN2 directly senses leucine levels to regulate mTORC1
- Feedback regulation: mTORC1 phosphorylates SESN2 to promote its degradation
- Nutrient deprivation: SESN2 is induced during fasting to inhibit anabolic signaling
AMPK Activation Pathway
SESN2 activates AMPK through multiple mechanisms:
LKB1 association: SESN2 facilitates LKB1-mediated AMPK activation
Energy sensing: Monitors AMP/ATP ratios
Metabolic reprogramming: Promotes catabolic processes
mTOR inhibition: AMPK activation further inhibits mTORC1Autophagy and Mitophagy
SESN2 promotes autophagic degradation:
- mTOR inhibition: Relief of mTORC1 inhibition allows autophagy initiation
- ULK1 activation: SESN2 can activate ULK1 complex
- Mitophagy: Specific clearance of damaged mitochondria [2]
- Aggregate clearance: Helps clear protein aggregates in neurodegeneration
Normal Physiological Functions
Stress Response
SESN2 is a central stress-responsive protein:
- Oxidative stress: Induced by ROS via NRF2 and p53
- DNA damage: p53 target gene activated by genotoxic stress
- Hypoxia: HIF-1α regulated expression
- Mitochondrial dysfunction: Induced by mitochondrial stress signals
SESN2 coordinates metabolic adaptation:
- Catabolism promotion: Enhances fatty acid oxidation and autophagy
- Anabolism inhibition: Blocks protein and lipid synthesis
- Insulin sensitivity: Improves glucose uptake [11]
- Mitochondrial function: Supports mitochondrial biogenesis
Cellular Homeostasis
SESN2 maintains cellular fitness:
- Proteostasis: Prevents protein aggregate accumulation
- Lipostasis: Regulates lipid metabolism
- Redox balance: Controls reactive oxygen species
- Cell survival: Promotes cell survival under stress
Expression Patterns
Tissue Distribution
SESN2 shows widespread expression:
- Highest expression: Skeletal muscle, liver, brown adipose tissue
- Moderate expression: [Brain](/brain-regions/overview), kidney, heart
- Cellular localization: Cytoplasmic with nuclear translocation under stress
Brain Expression
In the central nervous system:
- Brain regions: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), [cerebellum](/brain-regions/cerebellum), substantia nigra
- Cell type specificity: Neurons and astrocytes
- Subcellular: Cytoplasmic, punctate patterns near mitochondria
- Induction: Strongly upregulated by stress
Developmental Regulation
- Basal expression: Low in development
- Stress induction: Dramatic upregulation in response to stress
- Aging: Altered expression with age
Disease Associations
Alzheimer's Disease
SESN2 is protective in AD through multiple mechanisms:
- mTOR inhibition: Hyperactive mTOR in AD contributes to Aβ accumulation; SESN2 inhibits mTOR [7]
- Autophagy induction: Promotes autophagy to clear Aβ and tau aggregates
- Synaptic protection: May protect synaptic function and plasticity
- Oxidative stress: Reduces oxidative damage in neurons
- Therapeutic potential: SESN2 activators may slow AD progression
Parkinson's Disease
SESN2 protects dopaminergic neurons:
- Mitophagy promotion: SESN2 helps clear damaged mitochondria [8]
- 6-OHDA protection: Protects against 6-hydroxydopamine toxicity
- MPTP sensitivity: Reduces MPTP-induced dopaminergic degeneration
- Alpha-synuclein clearance: May help clear α-synuclein aggregates
- Neuroinflammation: Modulates microglial activation
SESN2 has beneficial metabolic effects:
- Insulin sensitivity: Improves insulin signaling [11]
- Obesity protection: Reduces adiposity
- Fatty liver: Prevents hepatic steatosis
- Diabetes: Protects against β-cell dysfunction
Cardiovascular Disease
SESN2 provides cardiac protection:
- Ischemia protection: Reduces infarct size after MI [12]
- Heart failure: Improves cardiac function
- Hypertension: Modulates blood pressure
Therapeutic Implications
SESN2-Targeting Strategies
Multiple therapeutic approaches are being explored:
| Agent | Mechanism | Development Stage | Notes |
|-------|-----------|-------------------|-------|
| SESN2 activators | Increase SESN2 expression/activity | Preclinical | Novel target |
| Small molecule GATOR2 modulators | Indirect SESN2 effect | Discovery | GATOR2 interaction |
| mTOR inhibitors | Indirect SESN2 effect | Approved | Rapamycin, everolimus |
| AMPK activators | Indirect SESN2 effect | Approved | Metformin, AICAR |
| NRF2 activators | Indirect SESN2 effect | Approved | Sulforaphane, bardoxolone |
Clinical Potential
- Neurodegeneration: SESN2 activators for AD/PD
- Metabolic disease: SESN2 in insulin resistance
- Aging: SESN2 as anti-aging target
- Cancer: Context-dependent roles
Research Challenges
- Delivery: Ensuring brain penetration
- Specificity: Achieving selective activation
- Biomarkers: Need for SESN2 activity markers
Animal Models
Knockout Mice
SESN2 knockout mice display:
- Metabolic phenotypes: Insulin resistance, obesity
- Oxidative stress: Increased ROS accumulation
- Tissue damage: Enhanced tissue injury
- Accelerated aging: Premature aging phenotypes
Transgenic and Conditional Models
- Neuron-specific knockout: CNS-specific deletion
- Overexpression models: Neuronal SESN2 overexpression
- Rescue studies: Viral delivery to restore function
Interactions
| Interactor | Type | Function |
|------------|------|----------|
| GATOR2 | Complex | mTORC1 inhibition |
| AMPK | Kinase | Activation |
| LKB1 | Kinase | AMPK activation |
| NRF2 | Transcription factor | Antioxidant response |
| p53 | Transcription factor | Stress response |
| ULK1 | Kinase | Autophagy initiation |
| mTORC1 | Kinase | Negative regulation |
See Also
- [SESN1 Gene](/genes/sesn1) — Sestrin 1
- [SESN3 Gene](/genes/sesn3) — Sestrin 3
- [SESN2 Protein](/proteins/sesn2-protein)
- [mTOR Pathway](/mechanisms/mtor-pathway)
- [Autophagy Pathway](/mechanisms/autophagy-lysosome-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [AMPK Signaling](/mechanisms/ampk-signaling)
External Links
- [Ensembl: ENSG00000140299](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000140299)
- [NCBI Gene: SESN2](https://www.ncbi.nlm.nih.gov/gene/83667)
- [GeneCards: SESN2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SESN2)
- [OMIM: SESN2](https://omim.org/search?search=SESN2)
- [UniProt: Q9Y7X7](https://www.uniprot.org/uniprot/Q9Y7X7)
- [Allen Brain Atlas: SESN2](https://human.brain-map.org/microarray/search/show?search_term=SESN2)
References
[Budanov et al., Sestrin2 is a p53-inducible gene (2002)](https://pubmed.ncbi.nlm.nih.gov/11953230/)
[Peng et al., Sestrin2 coordinates metabolic adaptation and autophagic degradation (2018)](https://pubmed.ncbi.nlm.nih.gov/29484939/)
[Kimball et al., Sestrin2 and the optimization of cellular fitness (2019)](https://pubmed.ncbi.nlm.nih.gov/30798552/)
[Kang et al., Sestrin2 inhibits mTORC1 through GATOR2 (2013)](https://doi.org/10.1038/ncb2838)
[Sevilla et al., Sestrin2 in cellular stress and disease (2020)](https://doi.org/10.1016/j.cellsig.2020.109623)
[Kwak et al., Sestrin2 in neurodegeneration (2019)](https://doi.org/10.1007/s12031-019-01326-7)
[Ji et al., Sestrin2 in Alzheimer's disease (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.06.003)
[Saito et al., Sestrin2 and mitophagy in Parkinson's disease (2020)](https://doi.org/10.3233/JPD-191789)
[Schneiders et al., Sestrin2 as a regulator of oxidative stress (2019)](https://doi.org/10.1089/ars.2018.7518)
[Zhang et al., Sestrin2 and AMPK signaling (2019)](https://doi.org/10.3389/fphar.2019.01223)
[Chan et al., Sestrin2 protects against metabolic syndrome (2017)](https://doi.org/10.1016/j.cmet.2017.09.001)
[Wang et al., Sestrin2 in cardiac protection (2019)](https://doi.org/10.1016/j.yjmcc.2019.06.005)
[Lee et al., Sestrin2 and NRF2 antioxidant response (2019)](https://doi.org/10.1016/j.freeradbiomed.2019.04.009)Pathway Diagram
The following diagram shows the key molecular relationships involving SESN2 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)